Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated earnings guidance for the fiscal year ending December 31, 2022. For the year, the company expects revenue of JPY 7 million, operating loss of JPY 2,000 million, net loss of JPY 2,000 million and basic loss per share of JPY 43.61.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75 JPY | +1.35% |
|
0.00% | -6.25% |
1st Jan change | Capi. | |
---|---|---|
-6.25% | 26.39M | |
+63.05% | 856B | |
+39.56% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.60% | 234B | |
+16.52% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022